# Efficacy of Oral Tofacitinib in Combination of Narrow Band UVB in Treatment of Vitiligo

> **NCT07044141** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Lahore General Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Vitiligo

## Interventions

- **DRUG:** Azathioprine
- **DRUG:** Tofacitinib

## Key facts

- **NCT ID:** NCT07044141
- **Lead sponsor:** Lahore General Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-03-01
- **Primary completion:** 2025-09-30
- **Final completion:** 2025-09-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07044141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07044141, "Efficacy of Oral Tofacitinib in Combination of Narrow Band UVB in Treatment of Vitiligo". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07044141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*